Results

Total Results: 1,851 records

Showing results for "adverse".

41. App-E-Surv-Report-2-Acute-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-acute-pain.xlsx
    September 20, 2022 - Events Adverse Events Withdrawals Due to Adverse Events Sponsor Quality Skonnord, 2020 Outpatient Norway … Events Adverse Events Withdrawals Due to Adverse Events Sponsor Quality Akgol Gur, 2020 Emergency department … Events Adverse Events Withdrawals Due to Adverse Events Sponsor Quality Bloom, 2021 Postoperative to … Events Adverse Events Withdrawals Due To Adverse Events Sponsor Quality Cooper, 2021 Outpatient U.S … B Any adverse event: 52.7% (15/46) vs. 8.8% (3/34), p=0.002 Any severe adverse event: 16.7% (6/36) vs

42. Draft-Appendix-Pbt-Cohort-Studies (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/draft-appendix-pbt-cohort-studies.xlsx
    May 11, 2021 - Outcomes Quality of Life Outcomes Anxiety and Depression Outcomes Sleep Outcomes Opioid Use Outcomes Adverse … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. … NR Serious adverse events: none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious … adverse events: 13% (28/215) vs. 19.4% (42/216), OR 0.64 (95% CI 0.38 to 1.04) Withdrawals due to adverse

43. Integrating stakeholder preferences in comparative effectiveness research using multi-criteria decision analysis (MCDA) and Conjoint Analysis (CA) (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
    January 01, 2011 - set of criteria (attributes and levels): • I want the best treatment: Clinical Outcome Adverse … Drug B partial relief high blood pressure 3 US$ Drug C partial relief No adverse … preference for the alternatives: • I want the best treatment: Clinical Outcome C1 = 0.5 Adverse … events points to: • Serious adverse events, which points to : o Suicide and attempted suicide o … Other serious adverse events • Adverse events, which points to: o Sexual dysfunction o Other adverse

44. Major-Depressive-Disorder Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/major-depressive-disorder_executive.pdf
    December 01, 2015 - events, withdrawals because of adverse events, serious adverse events, specific adverse events (including … because of adverse events. … of adverse events. … events, overall risk of serious adverse events, or discontinuation due to adverse events. … events, overall risk of serious adverse events, or discontinuation due to adverse events.

45. Adverse Effects of First-Line Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-depression-research-protocol.pdf
    February 07, 2018 - adverse effects of first-line pharmacologic treatments? … effects and comparative adverse effects of first-line pharmacologic treatments? … Outcomes: We are interested in the following adverse effects for KQ1 and KQ2: • Any adverse event … , as in those who experienced an adverse events • Withdrawal due to adverse events • Serious adverse … Effects • Adverse events • Withdrawal due to adverse events • Serious adverse events • Hospitalization

46. Research Protocol: Radiation Therapy for Brain Metastases (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/radiation-therapy-brain-metases-protocol.pdf
    October 10, 2019 - The broader inclusion criteria for adverse event data take into account that rare adverse events are … adverse events The appraisal of the data collection method will evaluate the rigor of the adverse … The reporting will also assess whether adverse events, including serious adverse events, were defined … Number of patients with serious adverse events 2. Number of adverse events 3. … What is a Serious Adverse Event?

47. Hip-Fracture-Pain Clinician (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
    May 01, 2011 - and Epidural Anesthesia: The evidence is insufficient to understand the effectiveness, benefits, or adverse … for pain relief, but the data are too limited to draw conclusions about the benefits or harms. ��� Adverse … Events Overall, adverse event rates were similar in both treated and control groups, but studies were … Serious adverse events such as myocardial infarction, stroke, and renal failure were either rarely reported … For all modalities, the evidence is generally inadequate to estimate harms and the incidence of adverse

48. Rheumatoid-Arthritis-Medicine Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
    April 01, 2012 - Low Discontinuation rates and severe adverse events higher with infliximab. … Low No differences in adverse events in efficacy studies. … Low No differences in adverse events in efficacy studies. … Low No differences in adverse events in efficacy studies. … Low No differences in serious adverse events between groups.

49. Plant-Based-Chronic-Pain-Review-Q3-Tables-F5 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-chronic-pain-review-q3-tables-f5.xlsx
    June 15, 2021 - Outcomes Quality of Life Outcomes Anxiety and Depression Outcomes Sleep Outcomes Opioid Use Outcomes Adverse … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. … NR Serious adverse events: none in any group Withdrawals due to adverse events 6 months: 10% (5/49) vs … B % (n/N) Any adverse event: 88.4% (190/215) vs. 85.2% (184/216), RR 1.02 (95% CI 0.88 to 1.18) Serious … adverse events: 13% (28/215) vs. 19.4% (42/216), OR 0.64 (95% CI 0.38 to 1.04) Withdrawals due to adverse

50. Evidence Summary_Comparative Effectiveness Review No. 250_Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2022 Update (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-evidence-summary-2022-update_0.pdf
    January 01, 2022 - There was no increase in risk of serious adverse events or withdrawal due to adverse events. … Some nonopioid treatments had frequent overall adverse events and some less frequent yet serious adverse … effects, while nonpharmacological treatments typically reported few adverse events.10 Cannabinoids … Other prioritized adverse events (cannabis use disorder [CUD], psychosis, cognitive deficits) and the … The evidence on adverse events with cannabis-related products is much less robust than the evidence

51. S96 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/s96.pdf
    October 01, 2007 - Pollock, MD* Background: Adverse drug events (ADEs) are an important cause of patient injury. … Adverse drug event data collection, National Elec- tronic Injury Surveillance System-Cooperative Adverse … The FDA safety information and adverse event reporting program. … How the US Food and Drug Administration defines and detects adverse drug events. … Incidence of adverse drug events and potential adverse drug events. Implications for prevention.

52. Migraine in Adults: Preventive Pharmacologic Treatments | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/migraine-prevention/research-2013
    April 18, 2013 - effects, and 26 (95% CI, 10 to 43) would discontinue treatments due to bothersome adverse effects. … Adverse effects leading to treatment discontinuation were examined in 68 RCTs. … effects and treatment discontinuation due to adverse effects. … For episodic migraine, approved drugs are effective but increase risk of adverse effects and treatment … discontinuation due to adverse effects.

53. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
    October 01, 2015 - Adverse Effects: Tests We included seven studies that evaluated adverse effects of various tests for … Adverse Effects: Treatments This Key Question addressed adverse effects of various treatments, including … events (SOE: low for local adverse events; insufficient for systemic adverse events). … MMC: Systemic adverse events Low BCG was associated with increased risk of any systemic adverse event … gemcitabine: Systemic adverse events Low There were no differences in systemic adverse events (1

54. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - See Key Question 3 on adverse events. … (Low) Mixed results for specific adverse events. … (Low) Mixed results for specific adverse events. … (Low) Mixed results for specific adverse events. … (Low) Mixed results for specific adverse events.

55. Rheumatoid-Arthritis-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - See Key Question 3 on adverse events. … (Low) Mixed results for specific adverse events. … (Low) Mixed results for specific adverse events. … (Low) Mixed results for specific adverse events. … (Low) Mixed results for specific adverse events.

56. Radiation Therapy for Brain Metastases: A Systematic Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/radiation-brain-metastases/protocol
    January 28, 2020 - The broader inclusion criteria for adverse event data take into account that rare adverse events are … adverse events The appraisal of the data collection method will evaluate the rigor of the adverse … The reporting will also assess whether adverse events, including serious adverse events, were defined … We will use the authors' classification of serious adverse events. … events) Number of patients with serious adverse events Number of adverse events Any specific adverse

57. Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_disposition-comments.pdf
    January 01, 2020 - In the results section, each table of adverse events is labeled ‘reported adverse events.’ … Line 33- How are serious adverse events defined? … events,” “systemic adverse events,” “one or more adverse events” or “serious adverse events,” rather … The study collected only serious adverse events. … events,” “systemic adverse events,” “one or more adverse events” or “serious adverse events” rather

58. Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
    January 01, 2020 - In the results section, each table of adverse events is labeled ‘reported adverse events.’ … Line 33- How are serious adverse events defined? … events,” “systemic adverse events,” “one or more adverse events” or “serious adverse events,” rather … The study collected only serious adverse events. … events,” “systemic adverse events,” “one or more adverse events” or “serious adverse events” rather

59. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
    September 01, 2011 - In children with JIA, do the rate and type of adverse events differ between: a. … The rate and type of adverse events did not differ between treatment groups in these studies. … comparisons of the rate and type of adverse events among the various DMARDs. … • Reporting of adverse events. … Few high-quality data are available regarding the adverse events associated with DMARDs.

60. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
    January 01, 2007 - Also, ACEIs are associated with well-known adverse events not shared by ARBs, including cough (estimated … For adult patients with essential hypertension, how do ACEIs and ARBs differ in safety,4 adverse events … events, withdrawals due to adverse events, serious adverse events reported, withdrawal rates, and switch … For RCTs, this translates to a difference in rates safety, adverse events, tolerability, to Moderate … There was no evidence of differences in rates of other commonly reported specific adverse events.